Warlord 181 mg/ml is a blended anabolic formulation containing multiple fast-acting androgenic compounds, including injectable suspensions and orally active 17-alpha-alkylated steroids incorporated into a single injectable preparation.
Label-Indicated Composition (per ml)
-
Trenbolone Suspension – 50 mg
-
Testosterone Suspension – 50 mg
-
Methyltrienolone – 15 mg
-
Oxymetholone – 50 mg
-
Halotestin (Fluoxymesterone) – 15 mg
-
Mibolerone – 1 mg
Pharmacological Characteristics
This blend includes:
-
Non-esterified suspensions (rapid systemic release)
-
Highly androgenic compounds
-
17-alpha-alkylated agents, known for liver stress potential
-
Strong androgen receptor binding activity
Such combinations are typically associated with significant endocrine disruption and systemic strain.
Safety Considerations
Compounds in this formulation are associated with:
-
Severe hepatotoxicity risk (particularly methyltrienolone, oxymetholone, halotestin)
-
Cardiovascular strain and lipid disruption
-
Extreme hormonal suppression
-
Elevated blood pressure
-
Neuropsychiatric effects
-
Fertility suppression
Medical oversight is critical when dealing with hormone-modulating substances of this potency.

